TrialJAMA cardiology2019

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.

Mariusz Tomaniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.